EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Acceptability of cervical cancer screening among adolescent girls and young women living with HIV in Uasin Gishu County, Kenya

Annet Awuor Oyoyo, Shehu Shagari Awandu, Dickens Omondi Aduda, Daniel Onguru

African Journal of Health Sciences · 2026-01-23 · 38 (2)

DOI: 10.4314/ajhs.v38i2.7 ↗
AbstractBibliografische Angaben

Abstract

Background: Cervical cancer is a major cause of mortality among women living with HIV worldwide, especially among adolescent girls and young women (AGYW), who face a sixfold increased risk of Human Papillomavirus (HPV) infection with lower clearance rates compared to their HIV-negative peers. Despite the Ministry of Health recommendations for annual cervical cancer screening, only 23% of AGYW living with HIV in Uasin Gishu County have been screened. Identifying the client-level, healthcare worker, and service delivery factors that influence the uptake of cervical cancer screening could uncover barriers to acceptability. Methodology: A cross-sectional study was conducted to gather data from 196 HIV-positive AGYW, with enrollment carried out via systematic random sampling between November and December 2023. Data were collected using a pre-tested, structured questionnaire and analyzed using R version 4.3.1, applying chi-square tests and multiple logistic regression to explore associations between variables. Results: The study enrolled 168 AGYW, revealing that only 27% (46/168) had undergone cervical cancer screening. Key predictors of screening included familiarity with screening methods (AOR=4.71, 95% CI [ 1.71, 14.6], p=0.004), employment status (AOR= 7.45, 95% CI [2.47, 24.9], p

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →